This work was described ‘a highly significant advance’ in the use of G. mellonella larvae since it ‘opens the possibility of examining neural disease and repair mechanisms’, and ‘for rapidly evaluating the efficacy of novel drugs designed to counter a variety of neural diseases or malfunction’ (Browne and Kavanagh 2013 ).
← all excerpts
Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs.
1
—
—